anonymous
Guest
anonymous
Guest
I’m hoping so bc the micro managing here is becoming ungodly. WtF? Had one week of meetings, then team call a few days later then one on one calls a few days later. The culture sucks. Talk about a new culture etc but always default to big pharma. Ugh. They also didn’t understand market imo using ZS as usual. Many territories are dominated by a few large accounts and then who do you call on? Access is challenging and they didn’t realize that I think. ZS sold them on number of hematologists in territory not patients? WTH? Peace out.
This is exactly why I declined to move forward during the RD interviews. Had a long conversation with them about how they were building and who they were using as a vendor for assistance and decided it wasn't for me. That and the extremely low amount of equity they were offering made it seem like a mediocre opportunity at best.